## 3 Results  
Table 2 shows that, depending on the region affected by MSDs, 28.3-11.5% of Ds and 29.4-10.3% of DAs were aware of suitable medical therapies for the MSDs. The difference between the occupational groups regarding the use of medicines for treating MSDs was significant for the neck (\(p=0.02\)); however, after a Bonferroni-Holm correction, this significance did not hold. The Intake of Medication against MSDs  
Table 3 shows that Ds (60.0-33.3%) and DAs (71.4-27.3%) were most likely to take one single medication to treat MSDs. This was true for all body regions with MSDs except for the elbow region (45.5% of DAs most often used two medications), the knee region (50.0% of Ds most often used no medication) and the hip regions (30.0% of DAs used either no, or no medication). \begin{table}
\begin{tabular}{l c} \hline \hline \multicolumn{1}{c}{**Area of MSDs**} & **Medicinal Therapy** \\ \hline Neck & \\ Ds 308 (100) & 65 (21.1) * \\ DAs 369 (100) & 106 (28.7) * \\ \hline Shoulder & \\ Ds 260 (100) & 43 (16.5) \\ DAs 325 (100) & 54 (16.6) \\ \hline Elbow & \\ Ds 46 (100) & 13 (28.3) \\ DAs 45 (100) & 11 (24.4) \\ \hline Hand & \\ Ds 120 (100) & 15 (12.5) \\ DAs 173 (100) & 23 (13.3) \\ \hline Upper back & \\ Ds 167 (100) & 22 (13.2) \\ DAs 231 (100) & 41 (17.7) \\ \hline Lower back & \\ Ds 193 (100) & 54 (28.0) \\ DAs 204 (100) & 60 (29.4) \\ \hline Hip & \\ Ds 54 (100) & 9 (16.7) \\ DAs 72 (100) & 10 (13.9) \\ \hline Knee & \\ Ds 55 (100) & 10 (18.2) \\ DAs 82 (100) & 14 (17.1) \\ \hline Ankle & \\ Ds 26 (100) & 3 (11.5) \\ DAs 68 (100) & 7 (10.3) \\ \hline \hline \end{tabular}
\end{table} 
Table 2: Medical therapy of MSDs among Ds and DAs in Germany in \(n\) (%). one or two medication/s most often, while 33.3% of Ds used either no or one medication most often). The difference between the occupational groups with regard to the number of medications taken to treat MSDs was significant only for the neck region (\(p=0.05\)). After a Bonferroni-Holm correction, this significance did not hold. Table 4 shows that the most commonly chosen frequency of medication intake among Ds was \"as needed\" for MSDs of the neck (20.7%). Medications for MSDs of the shoulder (28.6%) and the upper back (31.6%) were most frequently taken monthly, while MSDs of the elbow were most often treated weekly (25.0%) and of the hand, daily (30.8%). The lower back (23.9%) and hip (33.3%) regions were most commonly treated \"as needed\" and daily. \begin{table}
\begin{tabular}{l c c c c c} \hline \hline \multicolumn{6}{c}{**Number of Medications**} \\ \cline{2-7} \multicolumn{1}{c}{**Area of MSDs**} & **0** & **1** & **2** & **3** & **4** \\ \hline Neck & & & & & \\ Ds * & 14 (21.2) & 30 (45.5) & 17 (25.8) & 3 (4.5) & 2 (3.0) \\ DAs * & 9 (8.5) & 62 (58.5) & 28 (26.4) & 7 (1.7) & - \\ \hline Shoulder & & & & & \\ Ds & 8 (18.6) & 22 (51.2) & 13 (30.2) & - & - \\ Das & 6 (10.7) & 31 (55.4) & 13 (23.2) & 6 (10.7) & - \\ \hline Elbow & & & & & \\ Ds & 2 (15.4) & 6 (46.2) & 4 (30.8) & 1 (7.7) & - \\ [PERSON] & 1 (9.1) & 3 (27.3) & 6 (54.5) & 1 (9.1) & \\ \hline Hand & & & & & \\ Ds & 2 (13.3) & 9 (60.0) & 3 (20.0) & 1 (6.7) & - \\ [PERSON] & 4 (17.4) & 12 (52.2) & 4 (17.4) & 3 (13.0) & - \\ \hline Upper back & & & & & \\ Ds & 5 (22.7) & 10 (45.5) & 6 (27.3) & 1 (4.5) & - \\ [PERSON] & 5 (12.2) & 27 (65.9) & 7 (17.1) & 2 (4.9) & - \\ \hline Lower back & & & & & \\ Ds & 9 (16.4) & 29 (52.7) & 13 (23.6) & 3 (5.5) & 1 (1.8) \\ Das & 5 (8.3) & 32 (53.3) & 14 (23.3) & 7 (11.7) & 2 (3.3) \\ \hline Hip & & & & & \\ Ds & 2 (22.2) & 5 (55.6) & 2 (22.2) & - & - \\ Das & 3 (30.0) & 3 (30.0) & 3 (30.0) & 1 (10.0) & - \\ \hline Knee & & & & & \\ Ds & 5 (50.0) & 4 (40.0) & 1 (10.0) & - & - \\ Das & 4 (28.6) & 8 (57.1) & 2 (14.3) & - & - \\ \hline Ankle & & & & & \\ Ds & 1 (33.3) & 1 (33.3) & - & - & 1 (33.3) \\ Das & 2 (28.6) & 5 (71.4) & - & - & - \\ \hline \hline \end{tabular} Significant differences (Chi-Quadrat-Test) are marked with an asterisk (* at \(p=0.05\)).  
\end{table}